Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review
Noémie Rabilloud, Pierre Allaume, Oscar Acosta, R. de Crevoisier, Raphaël Bourgade, Delphine Loussouarn, Nathalie Rioux‐Leclercq, Z. Khene, Romain Mathiéu, Karim Bensalah, Thierry Pécot, Solène‐Florence Kammerer‐Jacquet
Abstract
Deep learning (DL), often called artificial intelligence (AI), has been increasingly used in Pathology thanks to the use of scanners to digitize slides which allow us to visualize them on monitors and process them with AI algorithms. Many articles have focused on DL applied to prostate cancer (PCa). This systematic review explains the DL applications and their performances for PCa in digital pathology. Article research was performed using PubMed and Embase to collect relevant articles. A Risk of Bias (RoB) was assessed with an adaptation of the QUADAS-2 tool. Out of the 77 included studies, eight focused on pre-processing tasks such as quality assessment or staining normalization. Most articles (n = 53) focused on diagnosis tasks like cancer detection or Gleason grading. Fifteen articles focused on prediction tasks, such as recurrence prediction or genomic correlations. Best performances were reached for cancer detection with an Area Under the Curve (AUC) up to 0.99 with algorithms already available for routine diagnosis. A few biases outlined by the RoB analysis are often found in these articles, such as the lack of external validation. This review was registered on PROSPERO under CRD42023418661.